Jefferies raises Xeris Biopharma target price to $12 from $10
XERS•Jefferies raised its target price for Xeris Biopharma Holdings to $12 from $10.
Related News
Australian dollar gets a lift from kiwi, euro selling
TLT•
Symbotic director Charles Kane disposes of $85,895 of common shares
SYM•
Gold inches lower as firmer dollar, higher yields weigh
GLD•
US oil may retest support at $88.78
USO•
Japan bonds slide before 10-year auction amid fiscal worries at home and abroad
EWJ•